WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immuneering earnings were -$62.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest IMRX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$14.4M, down 4.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMRX reported annual earnings of -$61.0M, with 14.1% growth. The next IMRX earnings date is Nov 6, 2025.

IMRX earnings history

Current Revenue
$0.0
Current Earnings
-$62.1M
Current Profit Margin
0%

IMRX Return on Equity

Current Company
-146.3%
Current Industry
-10.1%
Current Market
30.7%
IMRX's Return on Equity (-146.3%)... subscribe to Premium to read more.
High Return on Equity Performance

IMRX undefined

Current Company
-117.2%
Current Industry
-0.2%
IMRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMRX announces earnings.

IMRX undefined

Current Company
-190.76%
Current Industry
6.4%
IMRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMRX-$61.43M-$62.13MN/A-$1.90
ALDX-$48.46M-$50.62MN/A-$0.85
GALT-$33.52M-$40.46MN/A-$0.64
LXEO-$112.01M-$114.17MN/A-$3.26
ABEO$79.97M$57.24MN/A$1.06
View Top Biotech Stocks

IMRX earnings dates

Next earnings date
Nov 6, 2025

Immuneering Earnings Reports & History FAQ

What were Immuneering's earnings last quarter?

On IMRX's earnings call on Invalid Date, Immuneering (NASDAQ: IMRX) reported Q2 2025 earnings per share (EPS) of -$0.40, up 14.89% year over year. Total IMRX earnings for the quarter were -$14.43 million. In the same quarter last year, Immuneering's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Immuneering stock.

When does Immuneering report earnings?

The next IMRX earnings date is Invalid Date. Add IMRX to your watchlist to be reminded of Immuneering's next earnings date.

Is Immuneering profitable or losing money?

As of the last Immuneering earnings report, Immuneering is currently losing money. Immuneering's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$62.13 million, a 10.81% increase year over year.

What was IMRX's earnings growth in the past year?

As of Immuneering's earnings date in Invalid Date, Immuneering's earnings has grown year over year. IMRX earnings in the past year totalled -$62.13 million.

What are Immuneering's earnings expectations?

The current EPS estimate for Immuneering's earnings report in Invalid Date is -$0.38.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.